Development and Validation of a UPLC-MS/MS Method for the Quantification of Components in the Ancient Classical Chinese Medicine Formula of Guyinjian
Nan Ge,
Zhineng Li,
Le Yang,
Guangli Yan,
Aihua Zhang,
Xiwu Zhang,
Xiuhong Wu,
Hui Sun,
Dan Li,
Xijun Wang
Affiliations
Nan Ge
National Chinmedomics Research Center, Heilongjiang University of Chinese Medicine, Heping Road 24, Harbin 150040, China
Zhineng Li
National Chinmedomics Research Center, Heilongjiang University of Chinese Medicine, Heping Road 24, Harbin 150040, China
Le Yang
State Key Laboratory of Dampness Syndrome, The Second Affiliated Hospital Guangzhou University of Chinese Medicine, Dade Road 111, Guangzhou 510120, China
Guangli Yan
National Chinmedomics Research Center, Heilongjiang University of Chinese Medicine, Heping Road 24, Harbin 150040, China
Aihua Zhang
National Chinmedomics Research Center, Heilongjiang University of Chinese Medicine, Heping Road 24, Harbin 150040, China
Xiwu Zhang
National Chinmedomics Research Center, Heilongjiang University of Chinese Medicine, Heping Road 24, Harbin 150040, China
Xiuhong Wu
National Chinmedomics Research Center, Heilongjiang University of Chinese Medicine, Heping Road 24, Harbin 150040, China
Hui Sun
National Chinmedomics Research Center, Heilongjiang University of Chinese Medicine, Heping Road 24, Harbin 150040, China
Dan Li
Beijing-Tianjin-Hebei Lianchuang Drug Research (Beijing) Co., Ltd., No. 100, Balizhuang Xili, Chaoyang District, Beijing 100025, China
Xijun Wang
National Chinmedomics Research Center, Heilongjiang University of Chinese Medicine, Heping Road 24, Harbin 150040, China
Guyinjian (GYJ) is an ancient classic formula of traditional Chinese medicine used for the treatment of liver and kidney yin deficiency; it was derived from the book “Jing Yue Quan Shu” in the Ming Dynasty. Modern clinical observation experiments have shown that GYJ has a definite therapeutic effect on the treatment of gynecological diseases such as kidney deficiency type oligomenorrhea, climacteric syndrome, intermenstrual bleeding, pubertal metrorrhagia, etc. However, the lack of GYJ quality control studies has greatly limited the development of its wider clinical application. In this study, a validated UPLC-MS/MS method was developed successfully for the first time and used to quantify fourteen compounds in GYJ samples with good specificity, linearity (r = 0.9960−0.9999), precision (RSD% ≤ 3.18%), stability (RSD% ≤ 2.22%) and accuracy (recovery test within 88.64–107.43%, RSD% at 2.82–6.22%). Simultaneously, the determination results of 15 batches of GYJ samples were analyzed by multivariate statistical methods, and it was found that the compounds have a greater influence on batch-to-batch stability, mainly Rehmannioside D, Loganin, Morroniside, Ginsenoside Re, and 3′,6-Disinapoylsucrose. The proposed new method has the advantages of high sensitivity, high selectivity, and rapid analysis, which provides a reference for the GYJ quality control study.